PROJECT TITLE: LOW-DOSE ERLOTINIB AND MESALAMINE FOR PREVENTION OF COLITIS-ASSOCIATED COLORECTAL CANCER (CAC)

DELIVERY ORDER won by THE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER · work in HOUSTON, TX
$691,578
RecipientTHE UNIVERISTY OF TEXAS M.D. ANDERSON CANCER CENTER UEI S3GMKS8ELA16
Award ID75N91025F00001
Award amount$691,578
Award typeDELIVERY ORDER
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN12
Start dateSep 25, 2025
End dateMar 24, 2027
Place of performanceHOUSTON, TX
Record updatedSep 22, 2025

View the official award record

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids